Form D · Biotechnology

ZWI Therapeutics, Inc.

Watertown, MA · CIK 0001854359

Offering snapshot reported Dec 23, 2022 · SEC filing

Reported sold
$0
Offering amount: $10M
Investors reported
2
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Mar 17, 2021
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$2.5M$5MMar 31, 2021: $5,000,000.00Mar 31, 2021Dec 23, 2022: $0.00Dec 23, 2022

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$5,000,000 → $0

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Dec 23, 2022Amendment$0-$5,000,000vs Mar 31, 20212SEC filing
Mar 31, 2021Initial$5,000,000No comparison2SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-394203

Source: Form D, filed Dec 23, 2022. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Xin Huang Director
Shaoyi Jiang Director
Andrew Keefe Director, Executive
Robert Langer Director
Cheng Xing Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
199 Dexter Avenue
Watertown, MA, 02472